Italy (IT)

Postdilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study on acute mechanistic effects (2016) Blachutzik F, Boeder N, Wiebe J, Mattesini A, Doerr O, Most A, Bauer T, et al. Conference contribution Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab (2016) Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, et al. Journal article Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry (2016) Schulman-Marcus J, Hartaigh BO, Gransar H, Lin F, Valenti V, Cho I, Berman D, et al. Journal article Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study (2016) Naber CK, Pyxaras SA, Nef H, Ijsselmuiden AJ, Briguori C, Schlundt C, Wykrzykowska J, et al. Journal article Consensus on Recording Deep Endometriosis Surgery: the CORDES statement (2016) Vanhie A, Meuleman C, Tomassetti C, Timmerman D, D'Hoore A, Wolthuis A, Van Cleynenbreugel B, et al. Journal article Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study (2016) Inglis SK, Carucci S, Garas P, Haege A, Banaschewski T, Buitelaar JK, Dittmann RW, et al. Journal article rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk (2016) Liu J, Loncar I, Collee JM, Bolla MK, Dennis J, Michailidou K, Wang Q, et al. Journal article Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2016) Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, Bolla MK, Dennis J, et al. Journal article An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression (2016) Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, et al. Journal article Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemacon A, Droit A, et al. Journal article